谷歌浏览器插件
订阅小程序
在清言上使用

Supplementary Figure from Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK–Positive Anaplastic Large Cell Lymphoma

M. Ceccon,L. Mologni, G. Giudici, R. Piazza,A. Pirola, D. Fontana,C. Gambacorti-Passerini

crossref(2023)

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要